<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>LA081690-0173</title>
	</head>
	<body>
		<main>
			<p><P> August 16, 1990, Thursday, Home Edition  </P> <P> BRIEFLY  </P> <P> Patent Dispute Ends: Genentech and Abbott Laboratories have agreed to drop  their counter claims over two Abbott patents on a substance known as  plasminogen activator. Genentech, of South San Francisco, said the out-of-court  settlement means that it can continue unrestricted sales of its tissue  plasminogen activator, a drug for treatment of heart attack victims.  </P></p>
		</main>
</body></html>
            